Role of nuclear factor-κB in volatile anaesthetic preconditioning with sevoflurane during myocardial ischaemia/reperfusion

European Journal of Anaesthesiology

Volumn 27, Issue 8, 2010, Pages 747-756

  Wang, Chen ^a   Xie, Hong ^b   Liu, Xia ^b   Qin, Qin ^b   Wu, Xuemei ^b   Liu, Hong ^c   Liu, Chunfeng ^d  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Second Affil Hosp Suzhou Med C   (China)

Author keywords

Ischaemia reperfusion; Nuclear factor B; Preconditioning; Sevoflurane

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PARTHENOLIDE; PENTOBARBITAL; PROTEIN BCL 2; SEVOFLURANE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOWN REGULATION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; MALE; MEDIATOR RELEASE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; UPREGULATION;

ANESTHETICS, INHALATION; ANIMALS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; METHYL ETHERS; MYOCARDIAL REPERFUSION INJURY; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77956842583     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32833bb3ba     Document Type: Article

References (34)

1. Lucchinetti E, Ambrosio S, Aguirre J, et al. Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. Anesthesiology 2007; 106:262-268.
2. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004; 101:299-310.
3. Wang C, Weihrauch D, Schwabe DA, et al. Extracellular signal-regulated kinases trigger isoflurane preconditioning concomitant with upregulation of hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in rats. Anesth Analg 2006; 103:281-288.
4. Hanouz JL, Zhu L, Lemoine S, et al. Reactive oxygen species mediate sevoflurane- and desflurane-induced preconditioning in isolated human right atria in vitro. Anesth Analg 2007; 105:1534-1539.
5. Eefting F, Rensing B, Wigman J, et al. Role of apoptosis in reperfusion injury. Cardiovasc Res 2004; 61:414-426.
6. Wu XW, Teng ZY, Jiang LH, et al. Human thioredoxin exerts cardioprotective effect and attenuates reperfusion injury in rats partially via inhibiting apoptosis. Chin Med J 2008; 121:819-826.
7. Lv X, Wan J, Yang J, et al. Cytochrome P450 v-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia-reperfusion. Eur J Pharmacol 2008; 596:118-126.
8. Xing B, Chen H, Zhang M, et al. Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat. Stroke 2008; 39:2362-2369.
9. Zhong C, Zhou Y, Liu H. Nuclear factor-kB and anesthetic preconditioning during myocardial ischemia reperfusion. Anesthesiology 2004; 100:540-546.
10. Konia MR, Schaefer S, Liu H. Nuclear factor-[kappa]B inhibition provides additional protection against ischaemia/reperfusion injury in delayed sevoflurane preconditioning. Eur J Anaesthesiol 2009; 26:496-503.
11. Bouwman RA, van't Hof FN, de Ruijter W, et al. The mechanism of sevoflurane-induced cardioprotection is independent of the applied ischaemic stimulus in rat trabeculae. Br J Anaesth 2006; 97:307-314.
12. Cain BS, Harken AH, Meldrum DR. Therapeutic strategies to reduce TNF-a mediated cardiac contractile depression following ischemia and reperfusion. J Mol Cell Cardiol 1999; 31:931-947.
13. Meldrum DR, Dinarello CA, Shames BD, et al. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-a production: Potential ultimate effector mechanism of preconditioning. Circulation 1998; 98:II214-II218.
14. Zandi E, Karin M. Bridging the gap: Composition, regulation, and physiological function of the IkB B kinase complex. Mol Cell Biol 1999; 19:4547-4551.
15. Li C, Kao RL, Ha T, et al. Early activation of IKKb during in vivo myocardial ischemia. Am J Physiol Heart Circ Physiol 2001; 280:H1265-H1271.
16. Redel A, Stumpner J, Tischer-Zeitz T, et al. Comparison of isoflurane-, sevoflurane-, and desflurane-induced pre and postconditioning against myocardial infarction in mice in vivo. Exp Biol Med 2009; 234:1186-1191.
17. Obal D, Dettwiler S, Favoccia C, et al. The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo. Anesth Analg 2005; 101:1252-1260.
18. Zingarelli B, Hake PW, Denenberg A, et al. Sesquiterpene lactone parthenolide, an inhibitor of IkappaB kinase complex and nuclear factorkappaB, exerts beneficial effects in myocardial reperfusion injury. Shock 2002; 17:127-134.
19. Wu XM, Liu X, Wang C, et al. The action time of parthenolide as selective nuclear factor-kB inhibitor in heart of rats. Chin J Biochem Pharm 2009; 30:365-367.
20. Lucchinetti E, Jamnicki M, Fischer G, et al. Preconditioning by isoflurane retains its protection against ischemia-reperfusion injury in postinfarct remodeled rat hearts. Anesth Analg 2008; 106:17-23.
21. Raphael J, Abedat S, Rivo J, et al. Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via Akt signaling and modulation of Bcl-2 family proteins. J Pharmacol Exp Ther 2006; 318:186-194.
22. Larsen JR, Aaqaard SR, Hasenkam JM, et al. Preocclusion ischaemia, not sevoflurane, successfully preconditions the myocardium against further damage in porcine in vivo hearts. Acta Anaesthesiol Scand 2007; 51:402-409.
23. Venkatapuram S, Wang C, Krolikowski GJ, et al. Inhibition of apoptotic protein P53 lowers the threshold of isoflurane-induced cardioprotection during early reperfusion in rabbits. Anesth Analg 2006; 103:1400-1405.
24. Wang C, Neff DA, Krolikowski GJ, et al. The influence of B-cell lymphoma 2 protein, an antiapoptotic regulator of mitochondrial permeability transition, on isoflurane-induced and ischemic postconditioning in rabbits. Anesth Analg 2006; 102:1355-1360.
25. Lu X, Liu H, Wang L, et al. Activation of NF-kappaB is a critical element in the antiapoptotic effect of anesthetic preconditioning. Am J Physiol Heart Circ Physiol 2009; 296:H1296-H1304.
26. Lutz J, Luong le A, Strobl M, et al. The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation. J Mol Med 2008; 86:1329-1339.
27. Coornaert B, Carpentier I, Beyaert R. A20: Central gatekeeper in inflammation and immunity. J Biol Chem 2009; 284:8217-8221.
28. Valen G, Paulsson G, Vaage J. Induction of inflammatory mediators during reperfusion of the human heart. Ann Thorac Surg 2001; 71:226-232; 18.
29. Bowie A, O'Neill LA. Oxidative stress and nuclear factor-kappaB activation: A reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000; 59:13-23.
30. Valen G, Yan ZQ, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 2001; 38:307-314.
31. Moss NC, Stansfield WE, Willis MS, et al. IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2007; 293:H2248-H2253.
32. Choi H, Kim SH, Chun YS, et al. In vivo hyperoxic preconditioning prevents myocardial infarction by expressing bcl-2. Exp Biol Med 2006; 231:463-472.
33. Misra A, Haudek SB, Knuefermann P, et al. Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. Circulation 2003; 108:3075-3078.
34. Grünenfelder J, Miniati DN, Murata S, et al. Upregulation of Bcl-2 through caspase-3 inhibition ameliorates ischemia/reperfusion injury in rat cardiac allografts. Circulation 2001; 104:I202-I206.